IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.811
-0.009 (-1.15%)
Nov 21, 2024, 10:52 AM EST - Market open
IO Biotech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 24.31 | 23.61 | 24.44 | 11.08 | 1.68 | 1.98 |
Research & Development | 72.11 | 67.83 | 46.99 | 30.15 | 8.46 | 7.94 |
Operating Expenses | 96.42 | 91.44 | 71.42 | 41.23 | 10.15 | 9.91 |
Operating Income | -96.42 | -91.44 | -71.42 | -41.23 | -10.15 | -9.91 |
Interest Expense | - | - | -0.3 | -0.36 | -0.03 | -0.01 |
Interest & Investment Income | 5.95 | 5.88 | 1.41 | - | - | - |
Currency Exchange Gain (Loss) | 1.48 | 0.33 | 0.13 | 0.32 | 0.11 | -0.04 |
EBT Excluding Unusual Items | -88.99 | -85.23 | -70.19 | -41.28 | -10.06 | -9.96 |
Other Unusual Items | - | - | - | -26.54 | -1.99 | -0.78 |
Pretax Income | -88.99 | -85.23 | -70.19 | -67.81 | -12.04 | -10.74 |
Income Tax Expense | 1.35 | 0.85 | 1.27 | 0.07 | - | - |
Net Income | -90.34 | -86.08 | -71.46 | -67.88 | -12.04 | -10.74 |
Preferred Dividends & Other Adjustments | - | - | - | 7.11 | 2.55 | 1.77 |
Net Income to Common | -90.34 | -86.08 | -71.46 | -74.99 | -14.59 | -12.52 |
Shares Outstanding (Basic) | 66 | 44 | 29 | 4 | 0 | 0 |
Shares Outstanding (Diluted) | 66 | 44 | 29 | 4 | 0 | 0 |
Shares Change (YoY) | 92.75% | 51.10% | 564.62% | 2346.74% | - | - |
EPS (Basic) | -1.37 | -1.98 | -2.48 | -17.30 | -82.36 | -70.64 |
EPS (Diluted) | -1.37 | -1.98 | -2.48 | -17.30 | -82.36 | -70.64 |
Free Cash Flow | - | -72.06 | -60.42 | -40.8 | -9.96 | -8.89 |
Free Cash Flow Per Share | - | -1.66 | -2.10 | -9.41 | -56.19 | -50.17 |
EBITDA | -96.16 | -91.23 | -71.32 | -41.23 | - | - |
D&A For EBITDA | 0.25 | 0.22 | 0.1 | 0 | - | - |
EBIT | -96.42 | -91.44 | -71.42 | -41.23 | -10.15 | -9.91 |
Source: S&P Capital IQ. Standard template.
Financial Sources.